BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Q, Wang J, Lu M, Qiu Y, Lu H. Acute-on-Chronic Liver Failure From Chronic-Hepatitis-B, Who Is the Behind Scenes. Front Microbiol 2020;11:583423. [PMID: 33365018 DOI: 10.3389/fmicb.2020.583423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ledoux N. Hepatitis B and Acute Liver Failure. Critical Care Nursing Clinics of North America 2022. [DOI: 10.1016/j.cnc.2022.04.012] [Reference Citation Analysis]
2 Sun J, Yu X, Weng Z, Jin L, Yang J, Zhang H, Gu J, Wang N, Yang J. The impact of hepatotoxic drugs on the outcome of patients with acute deterioration of hepatitis B virus-related chronic disease. Eur J Gastroenterol Hepatol 2022;34:782-90. [PMID: 35506899 DOI: 10.1097/MEG.0000000000002365] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xiong Y, Xia Z, Yang L, Huang J. Low T3 syndrome is associated with poor prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure. Expert Rev Gastroenterol Hepatol 2022;:1-7. [PMID: 35723536 DOI: 10.1080/17474124.2022.2090336] [Reference Citation Analysis]
4 Zhang J, Chen Y, Duan Z. Development of a FT3-related prognostic model for patients with hepatitis B virus-related acute-on-chronic liver failure. Bioengineered 2022;13:12548-57. [PMID: 35579389 DOI: 10.1080/21655979.2022.2077057] [Reference Citation Analysis]
5 Wang X, Zhong Y, Zhang R, Chen Y, Wang M, Lv C, Mao D. Wenyang Huazhuo Tuihuang Formula Inhibits the Th17/Treg Cell Imbalance and Protects against Acute-on-Chronic Liver Failure. Evid Based Complement Alternat Med 2022;2022:5652172. [PMID: 35399641 DOI: 10.1155/2022/5652172] [Reference Citation Analysis]
6 Liu Y, Meng X, Wang C, Zhang Y, Hua WW, Wang Z. Interleukin-18 Plays a Positive Feedback Activity to Natural Killer-Like B Cells in Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure. Viral Immunol 2021. [PMID: 35061511 DOI: 10.1089/vim.2021.0164] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Tan NH, Chen B, Peng J, Du S. Treg/Th17 Cell Balance in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure at Different Disease Stages. Biomed Res Int 2021;2021:9140602. [PMID: 34869773 DOI: 10.1155/2021/9140602] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Zhang Z, Yang Z, Cheng Q, Hu X, Liu M, Liu Y, Liu T, Ma K, Zhang M, Luo X, Chen T, Ning Q. Establishment and validation of a prognostic model for hepatitis B virus‑related acute-on-chronic liver failure patients with bacterial infection. Hepatol Int 2021. [PMID: 34855105 DOI: 10.1007/s12072-021-10268-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Huang L, Liu J, Bie C, Liu H, Ji Y, Chen D, Zhu M, Kuang W. Advances in cell death - related signaling pathways in acute-on-chronic liver failure. Clin Res Hepatol Gastroenterol 2021;:101783. [PMID: 34339873 DOI: 10.1016/j.clinre.2021.101783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Zhang Z, Ma K, Yang Z, Cheng Q, Hu X, Liu M, Liu Y, Liu T, Zhang M, Luo X, Chen T, Ning Q. Development and Validation of a Clinical Predictive Model for Bacterial Infection in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Infect Dis Ther 2021;10:1347-61. [PMID: 33991329 DOI: 10.1007/s40121-021-00454-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]